Part D Plans Undercut Generics In Favor Of Brands Only In 'Limited Instances' – CMS

 
• By Cathy Kelly
  
Brand Name or Generic - Traffic sign with two options - customer and dilemma of buying branded product vs no name commodity. Question of price and quality
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet